香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲 明，並明確表示，概不對因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 承董事會命 醫渡科技有限公司 執行董事兼董事長 宮盈盈 香港，2025年11月17日 於本公告日期，執行董事為宮盈盈女士、徐濟銘先生、封曉瑛女士及謝麗博士；非執行董事為曾鳴先生；及獨立非執行 董事為馬維英博士、潘蓉容女士及張林琦教授。 Yidu Tech Inc. 醫渡科技有限公司 ( 於 開 曼 群 島 註 冊 成 立 的 有 限 公 司 ) (股份代號：2158) 董事會會議通告 醫渡科技有限公司（「本公司」，連同其附屬公司及其綜合聯屬實體，統稱為「本集團」）董事 （「董事」）會（「董事會」）謹此宣佈，本公司將於2025年11月27日（星期四）舉行董事會會議，藉 以（其中包括）考慮及批准本集團截至2025年9月30日止六個月之未經審核合併中期業績及其 發佈以及考慮派發中期股息（如有）。 ...

Group 1 - The core viewpoint of the news highlights the successful launch of the "Beijing Universal Health Insurance" project, which gained significant attention from the public, achieving over 2 million participants within just 10 days of its launch in 2026 [1] - Yidu Technology (医渡科技) has been providing comprehensive technical support and operational services for the "Beijing Universal Health Insurance" for five consecutive years, contributing to the development of a multi-tiered medical security system in the capital [1] - The project requires a robust operational platform with capabilities in product design, system platform construction, marketing, customer service, and claims processing, emphasizing the need for strong technological capabilities [1] Group 2 - Yidu Technology utilizes its "Medical Intelligent Brain" YiduCore to create intelligent models and manage risk prediction for large populations, offering a one-stop solution for product design, system construction, platform operation, marketing, customer service, and claims processing [1] - The company has participated in the development and operation of health insurance projects in 5 provinces and 13 cities, including Beijing, Shenzhen, and Hebei [1] Group 3 - Market sentiment reflects confidence in Yidu Technology's growth prospects, as evidenced by significant net purchases from southbound funds, totaling 102.6 million shares on November 11 [2] - As of November 11, southbound funds held a total of 249 million shares of Yidu Technology, with a cumulative market value of 1.376 billion HKD, representing a holding ratio of 23.27% [2]

Core Insights - The National Healthcare Security Administration's Big Data Center announced the list of project undertakers for 2025, with Yidu Technology winning two projects related to AI-assisted classification of medical consumables and the construction of disease archives [1][2] - The projects align with the recent implementation opinions from the National Health Commission and other departments, emphasizing the integration of healthcare, medical insurance, and pharmaceuticals, showcasing the company's strong application capabilities in this field [1][2] Group 1 - The two awarded projects focus on "intelligent classification of medical consumables" and "standardization of disease archives," which are critical issues in current medical insurance reforms and data application [1] - The implementation opinions highlight the need to enrich medical data supply, promote collaboration among healthcare sectors, and enhance data sharing and compliance [1] Group 2 - Yidu Technology has over ten years of experience in medical big data and AI, having processed more than 6 billion medical records and covering over 4,000 medical institutions nationwide, impacting 1.15 billion patients [2] - The company's systematic capabilities support the collaboration of healthcare sectors and data interconnectivity, reflecting its excellence in data governance, modeling methodologies, and AI application [2] - Yidu Technology aims to deepen its focus on medical insurance big data, real-world research, and AI, driving the transformation of innovative results into practical applications for a new model of efficient and intelligent medical insurance governance [2]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | | | 致：香港交易及結算所有限公司 公司名稱: 醫渡科技有限公司 呈交日期: 2025年11月6日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02158 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 2,500,000,000 | USD | | 0.00002 USD | | 50,000 | | 增加 / 減少 (-) | | | 0 | | | USD | | 0 | | 本月底結存 | | | 2,500,000,000 | USD | | 0.00002 USD | | 50,000 | 第 2 頁 共 10 頁 v 1.1.1 III.已發行股份及/或庫存股份變動詳情 本月底法 ...

Group 1 - The "Sui Sui Kang" supplementary health insurance program in Guangzhou has opened for enrollment for the 2026 fiscal year, with over 2 million participants on the first day [1] - The program, initiated in December 2020, allows for insurance coverage without age or pre-existing condition restrictions, and offers reimbursement for self-paid medications without disease or drug type limitations [1] - The annual premium remains at 180 yuan, providing coverage up to 2.45 million yuan, including hospitalization, outpatient services, and more [1] Group 2 - The first five-year pilot of "Sui Sui Kang" has been successfully completed, with stable enrollment between 3.53 million and 3.84 million participants from 2021 to 2025, and an annual renewal rate exceeding 80% [3] - Over the five years, the program has provided coverage for 18.28 million instances, with 880,000 claims totaling 2.57 billion yuan, reducing the financial burden of medical expenses by 37.8% for claimants [3] - In 2026, the program will introduce a subsidy of 200 to 400 yuan for eligible insured individuals, enhancing participant satisfaction [3] Group 3 - Yidu Technology, a leader in AI healthcare, has developed the "AI Medical Brain" YiduCore, which offers comprehensive solutions for urban insurance programs, including product design, system setup, and intelligent claims processing [4] - The company has participated in the development and operation of "benefit insurance" projects across 5 provinces and 13 cities, serving over 40 million insured users [4] - Yidu Technology aims to leverage its technological expertise and operational capabilities to enhance the smart and inclusive service experience of the "Sui Sui Kang" program for Guangzhou residents [4]

Group 1 - The core viewpoint of the report indicates that the "14th Five-Year Plan" released by the 20th National Congress exceeds market expectations, alongside signs of easing US-China relations and strengthened expectations for US Federal Reserve interest rate cuts, which will support the Hong Kong stock market's transition from "suppressed" to "rising" in the fourth quarter [1] - As of October 24, southbound funds have accumulated holdings of 241 million shares in Hong Kong stocks, with a total market value of 1.368 billion HKD, representing a holding ratio of 22.48% [2] Group 2 - Medtronic Technology (2158.HK), an "AI + healthcare" company, has gained significant attention from southbound funds, with net purchases of 609,200 shares on October 24, amounting to a net buy of 3.4663 million HKD, marking 11 consecutive days of net buying and a total net purchase exceeding 100 million HKD [1] - Over the past 30 trading days, southbound funds have cumulatively net bought 14.4 million HKD of Medtronic Technology [1]

Core Viewpoint - Multiple companies, including China Feihe and Lianyi Rong Technology, conducted share buybacks on October 24, 2025, with China Feihe leading in both the number of shares repurchased and the total amount spent [1][2]. Group 1: Buyback Details - China Feihe (06186) repurchased 5.885 million shares for a total of 23.6977 million yuan, representing 0.087% of its total share capital [2]. - Lianyi Rong Technology (09959) repurchased 2.4 million shares for 7.3782 million yuan, accounting for 3.516% of its total share capital [2]. - Beike-W (02423) repurchased 1.1784 million shares for 7 million yuan, which is 1.722% of its total share capital [2]. Group 2: Other Notable Buybacks - Yum China (09987) repurchased 17,800 shares for 6.2549 million yuan, representing 2.830% of its total share capital [2]. - Mengniu Dairy (02319) repurchased 400,000 shares for 5.7447 million yuan, which is 0.545% of its total share capital [2]. - Kangsong Pharmaceutical (01681) repurchased 100,000 shares for 1.5180 million yuan, accounting for 8.582% of its total share capital [2].

Core Viewpoint - The company, Yidu Tech (02158), has been actively repurchasing its shares, indicating management's confidence in the stock's future appreciation potential [1] Group 1: Share Buyback Activity - On October 24, Yidu Tech repurchased approximately 21,200 shares for about 120,000 HKD in a single day [1] - The company has completed 10 share buybacks since September 26, totaling over 3.88 million ordinary shares and nearly 22.5 million HKD in total repurchase amount [1] Group 2: Total Return Swap Transaction - Yidu Tech announced a total return swap transaction with a nominal capital amount of approximately 54.4 million HKD, with Goldman Sachs as the counterparty, for a duration of about 3 years [1] - The purpose of this transaction is to hedge against the risk of future stock price appreciation, thereby reducing costs and cash flow risks associated with share purchases [1] Group 3: Market Sentiment and Stock Performance - Analysts believe that the signing of the total return swap indicates management's optimistic outlook on the company's future stock price appreciation [1] - As of October 24, Yidu Tech's stock price closed at 5.74 HKD, reflecting a 2.87% increase [2]

Core Viewpoint - The company, Yidu Tech (02158), has been actively repurchasing its shares, indicating management's confidence in the stock's future appreciation potential [1][2]. Group 1: Share Repurchase Activity - On October 24, Yidu Tech repurchased approximately 21,200 shares for about HKD 120,000 [1]. - The company has completed 10 repurchase transactions since September 26, totaling over 3.88 million ordinary shares and nearly HKD 22.5 million in total repurchase amount [1]. Group 2: Total Return Swap Transaction - On October 23, Yidu Tech announced a total return swap transaction with a nominal capital amount of approximately HKD 54.4 million, with Goldman Sachs as the counterparty [1]. - The transaction is set for a duration of about three years and aims to hedge against the risk of future stock price appreciation [1]. Group 3: Management's Perspective - Analysts interpret the signing of the total return swap as a sign of management's optimistic outlook on the company's future stock price [1]. - The strategy of acquiring shares at a low point to mitigate the risk of increased costs due to stock price appreciation reflects the company's proactive risk management approach [1].

Core Viewpoint - The company, Yidu Tech (02158.HK), announced a share buyback on October 24, 2023, spending HKD 120,000 to repurchase 21,000 shares [1] Group 1 - The total expenditure for the share buyback was HKD 120,000 [1] - The number of shares repurchased in this transaction was 21,000 [1]